Calliditas Therapeutics: On The Watch For Nefigard Data

Shares of Calliditas Therapeutics AB (CALT) have gained nearly 21% so far this month, as the company gears up for a clinical trial catalyst this quarter.

from RTT - Biotech https://ift.tt/359j2eU
via IFTTT